Lv41
770 积分 2021-08-09 加入
The global burden of early-onset type 2 diabetes mellitus caused by high body-mass index from 1990 to 2021 and projection to 2050
29天前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2个月前
已完结
Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based study
3个月前
已完结
SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
3个月前
已完结
SGLT2 inhibitors protect podocytes in lupus nephritis
3个月前
已完结
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis
4个月前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
4个月前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
4个月前
已完结
Efficacy of lifestyle weight loss interventions on regression to normoglycemia and progression to type 2 diabetes in individuals with prediabetes: a systematic review and pairwise and dose-response meta-analyses
5个月前
已完结
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
5个月前
已完结
皖公网安备34019202002308
